 Anemia, Sickle Cell
"Anemia, Sickle Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Descriptor ID |
D000755
|
| MeSH Number(s) |
C15.378.071.141.150.150 C15.378.420.155 C16.320.070.150 C16.320.365.155
|
| Concept/Terms |
Anemia, Sickle Cell- Anemia, Sickle Cell
- Anemias, Sickle Cell
- Sickle Cell Anemias
- Sickle Cell Disorders
- Cell Disorder, Sickle
- Cell Disorders, Sickle
- Sickle Cell Disorder
- Sickle Cell Anemia
- Sickle Cell Disease
- Cell Disease, Sickle
- Cell Diseases, Sickle
- Sickle Cell Diseases
- Sickling Disorder Due to Hemoglobin S
- Hemoglobin S Disease
- Disease, Hemoglobin S
- Hemoglobin S Diseases
|
Below are MeSH descriptors whose meaning is more general than "Anemia, Sickle Cell".
- Diseases [C]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Anemia [C15.378.071]
- Anemia, Hemolytic [C15.378.071.141]
- Anemia, Hemolytic, Congenital [C15.378.071.141.150]
- Anemia, Sickle Cell [C15.378.071.141.150.150]
- Hemoglobinopathies [C15.378.420]
- Anemia, Sickle Cell [C15.378.420.155]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Anemia, Hemolytic, Congenital [C16.320.070]
- Anemia, Sickle Cell [C16.320.070.150]
- Hemoglobinopathies [C16.320.365]
- Anemia, Sickle Cell [C16.320.365.155]
Below are MeSH descriptors whose meaning is more specific than "Anemia, Sickle Cell".
This graph shows the total number of publications written about "Anemia, Sickle Cell" by people in this website by year, and whether "Anemia, Sickle Cell" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 2 | 0 | 2 | | 1992 | 4 | 0 | 4 | | 1993 | 1 | 0 | 1 | | 1994 | 6 | 0 | 6 | | 1995 | 4 | 0 | 4 | | 1996 | 3 | 0 | 3 | | 1997 | 5 | 0 | 5 | | 1998 | 4 | 0 | 4 | | 1999 | 2 | 0 | 2 | | 2000 | 4 | 1 | 5 | | 2001 | 11 | 0 | 11 | | 2002 | 5 | 0 | 5 | | 2003 | 7 | 0 | 7 | | 2004 | 10 | 0 | 10 | | 2005 | 6 | 0 | 6 | | 2006 | 12 | 0 | 12 | | 2007 | 5 | 0 | 5 | | 2008 | 5 | 1 | 6 | | 2009 | 7 | 1 | 8 | | 2010 | 16 | 2 | 18 | | 2011 | 12 | 0 | 12 | | 2012 | 7 | 0 | 7 | | 2013 | 6 | 0 | 6 | | 2014 | 11 | 0 | 11 | | 2015 | 9 | 1 | 10 | | 2016 | 7 | 1 | 8 | | 2017 | 9 | 2 | 11 | | 2018 | 10 | 0 | 10 | | 2019 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Anemia, Sickle Cell" by people in Profiles.
-
Phillips S, Kanter J, Ruggiero KJ, Mueller M, Johnson MA, Kelechi TJ. An approach to revising mHealth interventions for children and families: A case example in sickle cell disease. Res Nurs Health. 2019 12; 42(6):483-493.
-
Brousseau DC, Richardson T, Hall M, Ellison AM, Shah SS, Raphael JL, Bundy DG, Arnold S. Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled Children. Pediatrics. 2019 07; 144(1).
-
Vichinsky E, Hoppe CC, Ataga KI, Ware RE, Nduba V, El-Beshlawy A, Hassab H, Achebe MM, Alkindi S, Brown RC, Diuguid DL, Telfer P, Tsitsikas DA, Elghandour A, Gordeuk VR, Kanter J, Abboud MR, Lehrer-Graiwer J, Tonda M, Intondi A, Tong B, Howard J. A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease. N Engl J Med. 2019 08 08; 381(6):509-519.
-
Maxwell SL, Schlenz AM, Kanter J. Health-related Quality of Life in Children With Sickle Cell Disease Undergoing Chronic Red Cell Transfusion Therapy. J Pediatr Hematol Oncol. 2019 05; 41(4):307-312.
-
Kutlar A, Kanter J, Liles DK, Alvarez OA, Cançado RD, Friedrisch JR, Knight-Madden JM, Bruederle A, Shi M, Zhu Z, Ataga KI. Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis. Am J Hematol. 2019 01; 94(1):55-61.
-
Kanter J, Abboud MR, Kaya B, Nduba V, Amilon C, Gottfridsson C, Rensfeldt M, Leonsson-Zachrisson M. Ticagrelor does not impact patient-reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study. Br J Haematol. 2019 01; 184(2):269-278.
-
DiMartino LD, Baumann AA, Hsu LL, Kanter J, Gordeuk VR, Glassberg J, Treadwell MJ, Melvin CL, Telfair J, Klesges LM, King A, Wun T, Shah N, Gibson RW, Hankins JS. The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease. Am J Hematol. 2018 12; 93(12):E391-E395.
-
Turnbull TL, Houston PM, Batalis NI. A Fatal Case of Necrotizing Pancreatitis in Sickle Cell Beta Thalassemia Zero. Am Surg. 2018 Sep 01; 84(9):e401-e402.
-
Ballas SK, Kanter J, Agodoa I, Howard R, Wade S, Noxon V, Dampier C. Opioid utilization patterns in United States individuals with sickle cell disease. Am J Hematol. 2018 10; 93(10):E345-E347.
-
Daak AA, Dampier CD, Fuh B, Kanter J, Alvarez OA, Black LV, McNaull MA, Callaghan MU, George A, Neumayr L, Hilliard LM, Sancilio F, Rabinowicz AL, Heeney MM. Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial). Blood Adv. 2018 08 14; 2(15):1969-1979.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|